新的“智能胰岛素”自动平衡1型糖尿病中的血糖,降低低血量,并允许每周注射一次。 A new "smart insulin" automatically balances blood sugar in Type 1 diabetes, reducing lows, and may allow weekly injections.

印地安那大学研究人员开发的一种新的“智能胰岛素”表明,通过自动调整血糖水平,有望减少1型糖尿病患者的低血糖症。 A new "smart insulin" developed by Indiana University researchers shows promise in reducing hypoglycemia in people with Type 1 diabetes by automatically adjusting blood glucose levels. 实验治疗结合了胰岛素和凝胶,形成一个响应葡萄糖水平的单分子,在高时降低浓度,在低时提高浓度。 The experimental treatment combines insulin and glucagon into a single molecule that responds to glucose levels, lowering them when high and raising them when low. 早期老鼠研究表明,改进了对葡萄糖的控制、无制冷的稳定性以及每周注射或使用泵的可能性。 Early rat studies show improved glucose control, stability without refrigeration, and potential for weekly injections or pump use. 虽然该技术仍处于早期开发阶段,但可以简化糖尿病管理,降低低血糖的危险,尽管需要人类试验和进一步研究。 While still in early development, the technology could simplify diabetes management and reduce the risk of dangerous low blood sugar, though human trials and further research are needed.